KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insulet (PODD) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Insulet (PODD) over the last 17 years, with Q3 2025 value amounting to $518.7 million.

  • Insulet's Accumulated Expenses rose 2522.94% to $518.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $518.7 million, marking a year-over-year increase of 2522.94%. This contributed to the annual value of $423.9 million for FY2024, which is 1343.32% up from last year.
  • Latest data reveals that Insulet reported Accumulated Expenses of $518.7 million as of Q3 2025, which was up 2522.94% from $453.4 million recorded in Q2 2025.
  • Insulet's 5-year Accumulated Expenses high stood at $518.7 million for Q3 2025, and its period low was $110.7 million during Q1 2021.
  • Over the past 5 years, Insulet's median Accumulated Expenses value was $301.0 million (recorded in 2022), while the average stood at $291.2 million.
  • As far as peak fluctuations go, Insulet's Accumulated Expenses soared by 9410.9% in 2023, and later surged by 1343.32% in 2024.
  • Insulet's Accumulated Expenses (Quarter) stood at $164.3 million in 2021, then skyrocketed by 83.2% to $301.0 million in 2022, then grew by 24.15% to $373.7 million in 2023, then grew by 13.43% to $423.9 million in 2024, then rose by 22.36% to $518.7 million in 2025.
  • Its Accumulated Expenses stands at $518.7 million for Q3 2025, versus $453.4 million for Q2 2025 and $378.6 million for Q1 2025.